United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sanofi - trimipramine maleate - oral tablet - 10mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

novartis pharmaceuticals uk ltd - mycophenolate sodium - gastro-resistant tablet - 360mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sun pharma uk ltd - montelukast sodium - oral tablet - 10mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

actavis uk ltd - prochlorperazine maleate - oral tablet - 5mg

United States - English - NLM (National Library of Medicine)

first priority incorporated - hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj), aluminum acetate (unii: 80ehd8i43d) (aluminum cation - unii:3xhb1d032b), acetic acid (unii: q40q9n063p) (acetic acid - unii:q40q9n063p) -

Singapore - English - HSA (Health Sciences Authority)

b. braun singapore pte ltd - orthopaedics - intended for the stabilization of the lumbar and thoracic spine through posterior approach, mono- and multisegmental

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: amb hk enterprises inc.; distributor: amb hk enterprises inc. - amlodipine (as besilate) - tablet - 5mg

Canada - English - Health Canada

neuraxpharm arzneimittel gmbh - methotrimeprazine (methotrimeprazine hydrochloride) - solution - 25mg - methotrimeprazine (methotrimeprazine hydrochloride) 25mg - phenothiazines

Singapore - English - HSA (Health Sciences Authority)

boston scientific asia pacific pte. ltd. - general & plastic surgery - the imager ii angiographic catheters are designed to provide a pathway for delivering contrast media to selected sites in the vascular system, including the carotid arteries.additionally, the imager ii 5f selective catheters without sideholes can also be used for the controlled and selective delivery of the boston scientific interlock™ -35 detachable coils into the peripheral vasculature.

Singapore - English - HSA (Health Sciences Authority)

boston scientific asia pacific pte. ltd. - cardiovascular - the promus elite everolimus-eluting platinum chromium coronary stent system is indicated for improving coronary luminal diameter in patients with symptomatic ischemic heart disease, including patients with acute myocardial infarction and patients with concomitant diabetes mellitus due to discrete de novo native coronary artery lesions. the promus elite everolimus-eluting platinum chromium coronary stent system is also indicated for treatment of patients presenting with: • coronary bifurcation lesions • coronary artery ostial lesions • unprotected left main coronary artery lesions • coronary artery total occlusion lesions • in-stent restenosis in coronary artery lesions the treated lesion length should be less than the nominal stent length (8 mm, 12 mm, 16 mm, 20 mm, 24 mm, 28 mm, 32 mm and 38 mm) with a reference vessel diameter of 2.25 mm - 4.00 mm.